SmartZyme Team

Our Team

Dr. Christopher Shepard

Position: Chief Development Officer

Dr. Shepard began his career at Genentech and has supported drug development programs from lead generation though pivotal development at Merck, Astellas, Celgene, and Boehringer Ingelheim in the areas of oncology and metabolism. For four years, he was at Structured BioEquity (SBE) where he in-licensed, structured deals, and built development programs around Phase 2 drug candidates.

Christopher holds a PhD (Honors) in Molecular Pathology from the University of Pittsburgh School of Medicine and an MBA from the Carnegie Mellon Tepper School of Business.

Interested in working with us?